Ett nytt studieresultat med AroCell TK 210 ELISA vid prostatacancer har accepterats för publicering
25 févr. 2019 02h30 HE
|
AroCell AB
Studien med titeln “The combination of AroCell TK 210 ELISA with Prostate Health Index (PHI) or PSA density can improve the ability to differentiate prostate cancer from non-cancerous conditions”,...
AroCell’s VD ger sin syn på företaget i en videointervju
13 févr. 2019 06h00 HE
|
AroCell AB
AroCell publicerar idag ett kort videointervju med Michael Brobjer, VD, och hans reflektion på de första månaderna i ledningen. Videon finns tillgänglig via länk nedan, på bolagets hemsida och via...
AroCell's CEO share his views on the company in a video interview
13 févr. 2019 06h00 HE
|
AroCell AB
Today AroCell publishes a short video interview with Michael Brobjer, CEO, and his reflections on his first months at Arocell. The video is available through the link below, AroCell website, and on...
AroCell lanserar ny hemsida
01 févr. 2019 07h32 HE
|
AroCell AB
Idag lanserar AroCell sin nya hemsida. Målet med den nya hemsidan är att underlätta för våra kunder, affärspartner och investerare att hitta relevant information om AroCell. Webbplatsen (arocell.com)...
AroCell launches new website
01 févr. 2019 07h32 HE
|
AroCell AB
Today AroCell is launching its new website. The goal with the new website is to facilitate for our customers, business partner, and investors to find relevant information about AroCell. The website...
AroCell tecknar distributörsavtal med Eurobio Scientific i Frankrike
20 déc. 2018 02h00 HE
|
AroCell AB
Arocell tillkännager idag att ett distributionsavtal har tecknats med det franska företaget Eurobio Scientific, för distribution av AroCell TK 210 ELISA i Frankrike och Schweiz. AroCell TK 210 ELISA...
AroCell signs distribution agreement with Eurobio Scientific in France
20 déc. 2018 02h00 HE
|
AroCell AB
AroCell AB (publ) announced today that a distribution agreement has been signed with the French company Eurobio Scientific, for distribution of AroCell TK 210 ELISA in France and Switzerland. AroCell...
New Publication from AroCell AB Demonstrating the Value of Thymidine Kinase 1 as a Tumor Biomarker
24 août 2018 07h50 HE
|
AroCell AB
A new review article has been published, Thymidine Kinase 1 as a tumor biomarker: technical advances offer new potential to an old biomarker, that analyses and summarizes recent publications...
ERYTECH to Webcast Presentation at the Jefferies Global Healthcare Conference
30 mai 2018 01h30 HE
|
Erytech Pharma S.A.
LYON, France, May 30, 2018 (GLOBE NEWSWIRE) -- ERYTECH Pharma (Euronext Paris:ERYP) (Nasdaq:ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating...
ERYTECH Reports First Quarter 2018 Financial Results and Provides Business Update
14 mai 2018 16h30 HE
|
Erytech Pharma S.A.
Finalized Phase 3 trial design for eryaspase in second line pancreatic cancer; on track for expected start of patient enrollment in Q3Selected triple-negative breast cancer as the next solid tumor...